Targeting ALT-Associated Vulnerabilities in Pediatric High-Grade Glioma
Targeting ALT-Associated Vulnerabilities in Pediatric High-Grade Glioma
Dr. Jihye Paik, Ph.D. – Weill Medical College of Cornell University, New York, NY
Development of a Measure of Social Connectedness for Survivors of Pediatric Brain Tumors
Development of a Measure of Social Connectedness for Survivors of Pediatric Brain Tumors
Dr. Matthew Hocking, Ph.D. – The Children's Hospital of Philadelphia, Philadelphia, PA
GLUL as a novel therapeutic target in pediatric T-ALL
GLUL as a novel therapeutic target in pediatric T-ALL
Dr. Daniel Herranz, Ph.D. – Rutgers Biomedical and Health Sciences (Rutgers Health), New Brunswick, NJ
Precision Epigenetic Therapies for Pediatric Burkitt Lymphoma
Precision Epigenetic Therapies for Pediatric Burkitt Lymphoma
Dr. Darko Barisic, Ph.D. – Weill Medical College of Cornell University, New York, NY
In a FLASH: reducing toxicity and enhancing cure for pediatric brain tumors
In a FLASH: reducing toxicity and enhancing cure for pediatric brain tumors
Dr. Sahaja Acharya, M.D. – Johns Hopkins University School of Medicine, Baltimore, MD
Uncovering the role of chromosome 21 in Down syndrome-associated leukemias
Uncovering the role of chromosome 21 in Down syndrome-associated leukemias
Dr. Jason Sheltzer, Ph.D. – Yale University, New Haven, CT
Development of a novel radiopharmaceutical agent for non-invasive immunotherapy target detection and CAR T combination therapy in neuroblastoma
Development of a novel radiopharmaceutical agent for non-invasive immunotherapy target detection and CAR T combination therapy in neuroblastoma
Dr. Rosa Nguyen, M.D., Ph.D. – National Cancer Institute, NIH NCI Pediatric Oncology, Bethesda, MD
HBEGF as a novel therapeutic target for Diffuse Midline Glioma
HBEGF as a novel therapeutic target for Diffuse Midline Glioma
Dr. Oren Becher, M.D. – Icahn School of Medicine at Mount Sinai, New York, NY
The impact of UBTF Tandem Duplications in Pediatric Acute Myeloid Leukemia
The impact of UBTF Tandem Duplications in Pediatric Acute Myeloid Leukemia
Dr. lannis Aifantis, Ph.D. – New York University Grossman School of Medicine, New York, NY
Targeting apoptosis to prevent cancer therapy-induced cardiovascular dysfunction in pediatric patients
Targeting apoptosis to prevent cancer therapy-induced cardiovascular dysfunction in pediatric patients
Dr. Kristopher Sarosiek, Ph.D. – President and Fellows of Harvard College, Harvard T. H. Chan School of Public Health, Boston, MA
Developing Human Cerebellar Organoid Models of Group 4 Medulloblastoma to Identify the Cell of Origin and Mechanisms that Support Oncogenesis
Developing Human Cerebellar Organoid Models of Group 4 Medulloblastoma to Identify the Cell of Origin and Mechanisms that Support Oncogenesis
Dr. Yanxin Pei, M.D. – Children's Research Institute (CNMC), Washington, D.C.
The Role of S100A8/A9-IL6R in B-ALL Chemoresistance
The Role of S100A8/A9-IL6R in B-ALL Chemoresistance
Dr. William Carroll, M.D. – New York University Grossman School of Medicine, New York, NY
Thyroid Hormone Induces Terminal Differentiation of Tumor Cells in Medulloblastoma
Thyroid Hormone Induces Terminal Differentiation of Tumor Cells in Medulloblastoma
Dr. Zeng-jie Yang – The Research Institute of Fox Chase Cancer Center, Philadelphia, PA
Targeting the HMGA1 Chromatin Regulator in MLL1-Rearranged Pediatric Leukemia
Targeting the HMGA1 Chromatin Regulator in MLL1-Rearranged Pediatric Leukemia
Dr. Linda Resar – Johns Hopkins University School of Medicine, Baltimore, MD
Deciphering the Immune Microenvironment in Alveolar Rhabdomyosarcoma
Deciphering the Immune Microenvironment in Alveolar Rhabdomyosarcoma
Dr. Brian Ladle - Johns Hopkins University School of Medicine, Baltimore, MD
Delineating molecular mechanisms of metastatic dissemination for medulloblastoma therapy
Delineating molecular mechanisms of metastatic dissemination for medulloblastoma therapy
Dr. Baoli Hu – University of Pittsburgh, Pittsburgh, PA
Dual-label optical genome mapping for the identification of novel co-occurring genetic and epigenetic alterations in diffuse midline gliomas
Dual-label optical genome mapping for the identification of novel co-occurring genetic and epigenetic alterations in diffuse midline gliomas
Dr. Miriam Bornhorst – Children's National Health System Department of Neurology, Washington D.C.
Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma
Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma
Dr. Oren Becher – Icahn School of Medicine at Mount Sinai, New York, NY
Epigenetic targeting of radiation resistant medulloblastoma
Epigenetic targeting of radiation resistant medulloblastoma
Johns Hopkins University, Baltimore, MD
Therapeutical reprogramming of DIPG cells
Therapeutical reprogramming of DIPG cells
Joan & Sanford I. Weill Medical College of Cornell University, New York, NY